Answers are grounded in this paper and cite their sources.
Paranoia is a transdiagnostic phenomenon defined by enduring and unjustified fears that others may wish to cause harm. This spectrum ranges from mild suspiciousness observed in the general population to intense persecutory beliefs found in psychotic disorders. This narrative review synthesizes the existing evidence regarding the historical development, diagnostic classification, neurobiological mechanisms, cognitive processes, therapeutic approaches, and psychosocial factors related to paranoia. Current diagnostic perspectives informed by the DSM-5-TR and ICD-11 are examined, focusing on differential diagnosis and the dimensional characteristics of paranoid experiences. Evidence indicates that genetic susceptibility, along with dopaminergic, glutamatergic, and serotonergic mechanisms, altered threat processing, and cognitive biases, may play a role in the development of paranoia. However, it is important to note that much of the neurobiological evidence stems from studies on psychosis or schizophrenia and is primarily associative rather than causal. Management should be informed by the foundational psychiatric disorder, the severity of symptoms, the degree of functional impairment, and the preferences of the patient. Pharmacological treatment may involve the use of antipsychotic agents when clinically warranted. In contrast, psychological interventions such as Cognitive Behavioral Therapy for Psychosis (CBTp) and Metacognitive Training (MCT) demonstrate the most robust evidence among the reviewed approaches. The evidence supporting compassion-focused, mindfulness-based, and reasoning-focused interventions is relatively limited. Digital interventions, virtual reality, and non-invasive neuromodulation techniques such as rTMS and tDCS are emerging methodologies that necessitate additional controlled research. The review also emphasizes the impact of trauma, social adversity, family environment, and cultural context on paranoid experiences. In summary, a dimensional and biopsychosocial framework could offer a more clinically relevant foundation for comprehending and addressing paranoia, while also acknowledging significant limitations within the existing evidence base.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: